China Universal Asset Management Company’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

China Universal Asset Management Company’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-477	Closed	-$1.87K	–	502
2023 Q3	$1.87K	Buy	477 +405	+563%	+$2.76K	﹤0.01%	435
2023 Q2	$234	Sell	72 -2	-3%	-$6	﹤0.01%	452
2023 Q1	$269	Buy	74 +18	+32%	+$278	﹤0.01%	447
2022 Q4	$1.79K	Buy	56 +5	+10%	+$198	﹤0.01%	380
2022 Q3	$2K	Buy	+51	New	+$2.33K	﹤0.01%	374

Other funds holding EVLO

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

China Universal Asset Management Company's EVLO Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 477 shares — an estimated $1.87K sold.

China Universal Asset Management Company first reported a position in EVLO in Q3 2022 and held it in 5 quarters. The position peaked at $2K in Q3 2022. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

China Universal Asset Management Company reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
China Universal Asset Management Company sold 477 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $1.87K.
China Universal Asset Management Company first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
China Universal Asset Management Company's Evelo Biosciences, Inc. Common Stock position peaked at $2K in Q3 2022.
2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.